Galderma Labs Patents Invalidated for Obviousness
19 Dec 2013
Last week, on December 11, 2013, in Galderma Labs., L.P. v. Tolmar, Inc., the U.S. Court of Appeals for the Federal Circuit (Newman, Bryson, Prost*) reversed the district court’s judgment that U.S. Patents No. 7,579,377, No. 7,737,181, No. 7,834,060, No. 7,838,558, and No. 7,868,044, (the Patents) were not invalid for obviousness under 35 U.S.C. §...